Treatment and Clinical Outcomes Among SLE Patients in Pregnancy

Recruiting now · Phase 1

Conditions studied: Systemic Lupus Erythematosus, Pregnancy Related

In brief

Systemic lupus erythematosus (SLE) is a kind of systemic autoimmune disease which can cause multiple organs and system damage, which often occurs in women of childbearing age. Compared with healthy pregnant women, SLE patients have higher incidence of premature delivery, preeclampsia and fetal loss during pregnancy. Since SLE patients usually have disease activity during pregnancy and postpartum, and a variety of maternal and fetal diseases are closely related to SLE, it is very important to monitor the disease activity and drug treatment of SLE patients during pregnancy.

Key facts

Study ID
NCT04976465
Run by
Qilu Hospital of Shandong University
People needed
200
Starts
2018-01-01
Expected to finish
2026-12-31
Last updated by the study team
2023-11-18

Who can join

Age: 20 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.